All Stories

  1. Reduced Variability to Aspirin Antiplatelet Effect by the Coadministration of Statins in High-Risk Patients for Cardiovascular Disease

    Article • Clinical Pharmacology & Therapeutics, April 2018, Wiley

    Professor Pietro Minuz, Dr Virgilio G Evangelista, Paola Patrignani

  2. Roflumilast inhibits leukocyte-platelet interactions and prevents the prothrombotic functions of polymorphonuclear leukocytes and monocytes

    Article • Journal of Thrombosis and Haemostasis, December 2015, Wiley

    Dr Virgilio G Evangelista

  3. The effect of rosuvastatin on thromboinflammation in the setting of acute coronary syndrome

    Article • Journal of Thrombosis and Thrombolysis, October 2014, Springer Science + Business Media

    Dr Virgilio G Evangelista

  4. Effect of Pioglitazone Versus Metformin on Cardiovascular Risk Markers in Type 2 Diabetes

    Article • Advances in Therapy, January 2013, Springer Science + Business Media

    Dr Virgilio G Evangelista

  5. Interactions Between Platelets, Leukocytes and the Endothelium

    Article • January 2013, Elsevier

    Dr Virgilio G Evangelista

  6. Effects of estrogen on endothelial prostanoid production and cyclooxygenase-2 and heme oxygenase-1 expression

    Article • Prostaglandins & Other Lipid Mediators, August 2012, Elsevier

    Dr Virgilio G Evangelista

  7. An Intense and Short-Lasting Burst of Neutrophil Activation Differentiates Early Acute Myocardial Infarction from Systemic Inflammatory Syndromes

    Article • PLoS ONE, June 2012, PLOS

    Dr Virgilio G Evangelista

  8. Glucose and collagen regulate human platelet activity through aldose reductase induction of thromboxane

    Article • Journal of Clinical Investigation, November 2011, American Society for Clinical Investigation

    Dr Virgilio G Evangelista

  9. Regulation of leukocyte recruitment by the long pentraxin PTX3

    Article • Nature Immunology, March 2010, Nature

    Dr Virgilio G Evangelista

  10. Ochratoxin A inhibits the production of tissue factor and plasminogen activator inhibitor-2 by human blood mononuclear cells: Another potential mechanism of immune-suppression

    Article • Toxicology and Applied Pharmacology, June 2008, Elsevier

    Dr Virgilio G Evangelista

  11. The C242T polymorphism of the p22phox component of NAD(P)H oxidase and vascular risk. Two case-control studies and a meta-analysis

    Article • Thrombosis and Haemostasis, February 2008, Schattauer GmbH

    Dr Virgilio G Evangelista

  12. Inhibition by soya isoflavones of human polymorphonuclear leukocyte function: possible relevance for the beneficial effects of soya intake

    Article • British Journal Of Nutrition, September 2007, Cambridge University Press

    Dr Virgilio G Evangelista

  13. Homocysteine Modulates the CD40/CD40L System

    Article • Journal of the American College of Cardiology, June 2007, Elsevier

    Dr Virgilio G Evangelista

  14. Aspirin and Simvastatin Combination for Cardiovascular Events Prevention Trial in Diabetes (ACCEPT-D): design of a randomized study of the efficacy of low-dose aspirin in the prevention of cardiovascular events in subjects with diabetes mellitus treate...

    Article • Current Controlled Trials in Cardiovascular Medicine, January 2007, Springer Science + Business Media

    Dr Virgilio G Evangelista

  15. The lipoxygenase–cyclooxygenase inhibitor licofelone prevents thromboxane A2-mediated cardiovascular derangement triggered by the inflammatory peptide fMLP in the rabbit

    Article • European Journal of Pharmacology, September 2006, Elsevier

    Dr Virgilio G Evangelista

  16. Src-family kinases mediate an outside-in signal necessary for β2 integrins to achieve full activation and sustain firm adhesion of polymorphonuclear leucocytes tethered on E-selectin

    Article • Biochemical Journal, May 2006, Portland Press Ltd.

    Dr Virgilio G Evangelista

  17. Clopidogrel inhibits platelet-leukocyte adhesion and platelet-dependent leukocyte activation

    Article • Thrombosis and Haemostasis, August 2005, Schattauer GmbH

    Dr Virgilio G Evangelista

  18. Prevention of cardiovascular disease in type-2 diabetes: How to improve the clinical efficacy of aspirin

    Article • Thrombosis and Haemostasis, December 2004, Schattauer GmbH

    Dr Virgilio G Evangelista

  19. SRC-dependent outside-in signalling is a key step in the process of autoregulation of beta2 integrins in polymorphonuclear cells

    Article • Biochemical Journal, May 2004, Portland Press Ltd.

    Dr Virgilio G Evangelista

  20. Licofelone, an inhibitor of cyclooxygenase and 5-lipoxygenase, specifically inhibits cyclooxygenase-1-dependent platelet activation

    Article • European Journal of Pharmacology, March 2004, Elsevier

    Dr Virgilio G Evangelista

  21. Licofelone, a dual lipoxygenase–cyclooxygenase inhibitor, downregulates polymorphonuclear leukocyte and platelet function

    Article • European Journal of Pharmacology, October 2002, Elsevier

    Dr Virgilio G Evangelista

  22. Inhibition of cGMP-dependent protein kinases potently decreases neutrophil spontaneous apoptosis

    Article • Biochemical and Biophysical Research Communications, September 2002, Elsevier

    Dr Virgilio G Evangelista

  23. Recent Advances in Platelet-Polymorphonuclear Leukocyte Interaction

    Article • Pathophysiology of Haemostasis and Thrombosis, January 1999, Karger Publishers

    Dr Virgilio G Evangelista

  24. Kinetic Evaluation of Endogenous Leukotriene B4 Ande4 Acute Activation of Inflammatory Cells in the Rabbit

    Article • January 1999, Springer Science + Business Media

    Dr Virgilio G Evangelista

  25. Effect of trans -resveratrol, a natural polyphenolic compound, on human polymorphonuclear leukocyte function

    Article • British Journal of Pharmacology, April 1998, Wiley

    Dr Virgilio G Evangelista

  26. Kinetics of Endogenous Leukotriene B4 and E4 Production Following Injection of the Chemotactic Peptide FMLP in the Rabbit

    Article • Prostaglandins, October 1997, Elsevier

    Dr Virgilio G Evangelista

  27. Platelet-Polymorphonuclear Leukocyte Functional Interactions: Role Of Adhesive Molecules

    Article • Pathophysiology of Haemostasis and Thrombosis, January 1996, Karger Publishers

    Dr Virgilio G Evangelista

  28. Platelet-released NAP-2 variants induce PMN leukocyte intracellular calcium changes ([Ca2+]i)

    Article • Pharmacological Research, January 1995, Elsevier

    Dr Virgilio G Evangelista

  29. Simultaneous determination of leukotrienes B4 and E4 in whole blood and of leukotriene E4 in urine of rabbit by reversed-phase high-performance liquid chromatography

    Article • Journal of Chromatography B Biomedical Sciences and Applications, August 1994, Elsevier

    Dr Virgilio G Evangelista

  30. Polymorphonuclear leucocyte-dependent modulation of platelet function: Relevance to the pathogenesis of thrombosis

    Article • Pharmacological Research, October 1992, Elsevier

    Dr Virgilio G Evangelista

  31. Inhibition by heparin of platelet activation induced by neutrophil-derived cathepsin G

    Article • European Journal of Pharmacology, June 1992, Elsevier

    Dr Virgilio G Evangelista

  32. Activated polymorphonuclear leukocytes stimulate platelet function

    Article • Thrombosis Research, January 1990, Elsevier

    Dr Virgilio G Evangelista

  33. Platelet–leukocyte interactions relevant to vascular damage and thrombosis

    Article • Cambridge University Press

    Dr Virgilio G Evangelista

  34. Platelets and tumours

    Article • Cambridge University Press

    Dr Virgilio G Evangelista